Wordt geladen...
Memantine treatment decreases levels of secreted Alzheimer’s amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells
Memantine, an uncompetitive NMDA receptor antagonist, is a FDA approved drug used for the treatment of moderate to severe Alzheimer’s disease (AD). Several studies have documented protective roles of memantine against amyloid beta peptide (Aβ)(–) mediated damage to neurons in both in vitro and in vi...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3379543/ https://ncbi.nlm.nih.gov/pubmed/19948208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2009.11.016 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|